Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
The future of clinical development hinges on viewing biological systems holistically. By integrating diverse molecular data ...
Pharmaceutical Technology on MSN
JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree
Multiple big pharma companies are reported to be circling Revolution, a cancer biotech with a market cap of $23bn.
Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...
A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned biotech chefs ready to light the burners. Soufflé Therapeutics will cook up siRNA medicines that are ...
With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One proposal comes from a Brazilian startup that will produce milk proteins without ...
PRINCETON, N.J. and SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a ...
A true pioneer in its field, NanoRay has built a solid reputation for being at the forefront of Taiwan’s X-ray technological innovation. After years of research and development, NanoRay’s transmission ...
Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem ...
The beauty industry has long harnessed biotechnology — namely taking the most powerful skincare ingredients in nature and recreating them using science to make them more potent, stable, ...
Eupraxia Pharmaceuticals is developing clinical candidates that employ its DiffuSphere technology, which delivers treatments to the targeted tissues. The company's candidates are currently EP-104GI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback